Private company

Longitude Capital Partners IV, LLC

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Longitude Capital Partners IV, LLC sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Longitude Capital Partners IV, LLC DE
- Ceribell, Inc. Stake · Sunnyvale, California, United States
- CG Oncology, Inc. Stake · Dallas, Texas
- Lexeo Therapeutics, Inc. Stake · New York, New York
- Vera Therapeutics, Inc. Stake · Brisbane, California
- Zenas BioPharma, Inc. Stake · Waltham, Massachusetts

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

Longitude Capital Partners IV, LLC has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

Lexeo Therapeutics, Inc.SCHEDULE 13G/A Feb 13, 2024 to Nov 14, 2025²
Zenas BioPharma, Inc.SCHEDULE 13D/A Sep 23, 2024 to Oct 14, 2025³
CG Oncology, Inc.SCHEDULE 13D Feb 5, 2024 to Sep 18, 2025⁴
Vera Therapeutics, Inc.SC 13D/A Apr 5, 2022 to Nov 4, 2024⁵
Ceribell, Inc.SC 13D Oct 22, 2024⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLongitude Capital Partners IV, LLC filings on SEC EDGAR
2
SEC EDGARLongitude Capital Partners IV, LLC SCHEDULE 13G/A on Lexeo Therapeutics, Inc.
3
SEC EDGARLongitude Capital Partners IV, LLC SCHEDULE 13D/A on Zenas BioPharma, Inc.
4
SEC EDGARLongitude Capital Partners IV, LLC SCHEDULE 13D on CG Oncology, Inc.
5
SEC EDGARLongitude Capital Partners IV, LLC SC 13D/A on Vera Therapeutics, Inc.
6
SEC EDGARLongitude Capital Partners IV, LLC SC 13D on Ceribell, Inc.